EPO and diabetes mellitus: In experimental rats with DM, intravitreal injection of EPO caused the increased number of erythropoietin receptors (EPOR) in neurosensory retina, with a protective effect against retinal neovascularisation and degenerative changes of photoreceptors [22, 23].